-
1 Comment
Beijing Science Sun Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 16.9% below its 200 day moving average.
From a valuation standpoint, the stock is 49.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.9.
Beijing Science Sun Pharmaceutical Co., Ltd's total revenue sank by 2.9% to $303M since the same quarter in the previous year.
Its net income has increased by 17.5% to $26M since the same quarter in the previous year.
Finally, its free cash flow fell by 104.3% to $-1M since the same quarter in the previous year.
Based on the above factors, Beijing Science Sun Pharmaceutical Co., Ltd gets an overall score of 2/5.
| ISIN | CNE100002110 |
|---|---|
| Sector | Healthcare |
| Exchange | SHE |
| CurrencyCode | CNY |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 5B |
|---|---|
| Beta | 0.37 |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300485.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
